Product NDC: | 0944-2700 |
Proprietary Name: | GAMMAGARD LIQUID |
Non Proprietary Name: | Human Immunoglobulin G |
Active Ingredient(s): | 100 mg/mL & nbsp; Human Immunoglobulin G |
Administration Route(s): | INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0944-2700 |
Labeler Name: | Baxter Healthcare Corporation |
Product Type: | PLASMA DERIVATIVE |
FDA Application Number: | BLA125105 |
Marketing Category: | BLA |
Start Marketing Date: | 20050427 |
Package NDC: | 0944-2700-04 |
Package Description: | 1 BOTTLE, GLASS in 1 CARTON (0944-2700-04) > 50 mL in 1 BOTTLE, GLASS |
NDC Code | 0944-2700-04 |
Proprietary Name | GAMMAGARD LIQUID |
Package Description | 1 BOTTLE, GLASS in 1 CARTON (0944-2700-04) > 50 mL in 1 BOTTLE, GLASS |
Product NDC | 0944-2700 |
Product Type Name | PLASMA DERIVATIVE |
Non Proprietary Name | Human Immunoglobulin G |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 20050427 |
Marketing Category Name | BLA |
Labeler Name | Baxter Healthcare Corporation |
Substance Name | HUMAN IMMUNOGLOBULIN G |
Strength Number | 100 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] |